SPY315.95-0.23 -0.07%
DIA259.79-0.93 -0.36%
IXIC10,548.21+55.71 0.53%

Homology Medicines Q3 EPS $(0.67) Misses $(0.60) Estimate, Sales $441K Miss $460K Estimate

Homology Medicines (NASDAQ:FIXX) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.6) by 11.67 percent. This is a 76.32 percent decrease over losses of $(0.38) per share

Benzinga · -

Homology Medicines (NASDAQ:FIXX) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.6) by 11.67 percent. This is a 76.32 percent decrease over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $441 thousand which missed the analyst consensus estimate of $460 thousand by 4.13 percent. This is a 72.47 percent decrease over sales of $1.602 million the same period last year.